RxNorm Semantic Concepts Index - 662
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "662".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 662 | Dicarboxylic amino acid | Designated preferred name (PT) | NO | |
RxCUI: 662 | Dicarboxylic amino acid | Full form of descriptor (FN) | NO | |
RxCUI: 662019 | Pralatrexate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 662019 | Pralatrexate | Designated preferred name (PT) | YES | |
RxCUI: 662019 | Pralatrexate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 662019 | Pralatrexate | Full form of descriptor (FN) | YES | |
RxCUI: 662019 | Pralatrexate | Designated preferred name (PT) | YES | |
RxCUI: 662019 | Pralatrexate | Designated preferred name (PT) | YES | |
RxCUI: 662019 | Pralatrexate | Full form of descriptor (FN) | YES | |
RxCUI: 662019 | Pralatrexate | Full form of descriptor (FN) | YES | |
RxCUI: 6622 | Maneb | Designated preferred name (PT) | NO | |
RxCUI: 6622 | Maneb | Full form of descriptor (FN) | NO | |
RxCUI: 6622 | Maneb | Designated preferred name (PT) | NO | |
RxCUI: 6622 | Maneb | Full form of descriptor (FN) | NO | |
RxCUI: 662263 | Product containing dorzolamide and timolol (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 662263 | Product containing dorzolamide and timolol (medicinal product) | Designated preferred name (PT) | YES | |
RxCUI: 662263 | Product containing dorzolamide and timolol (medicinal product) | Full form of descriptor (FN) | YES | |
RxCUI: 662281 | nilotinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 662281 | nilotinib | Designated preferred name (PT) | YES | |
RxCUI: 662281 | nilotinib | Full form of descriptor (FN) | YES | |
RxCUI: 662281 | nilotinib | Designated preferred name (PT) | YES | |
RxCUI: 662281 | nilotinib | Full form of descriptor (FN) | YES | |
RxCUI: 6623 | Mn - Manganese | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 6623 | Mn - Manganese | Designated preferred name (PT) | YES | |
RxCUI: 6623 | Mn - Manganese | Full form of descriptor (FN) | YES | |
RxCUI: 6623 | Mn - Manganese | Designated preferred name (PT) | YES | |
RxCUI: 6623 | Mn - Manganese | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 6623 | Mn - Manganese | Full form of descriptor (FN) | YES | |
RxCUI: 662564 | chlorpheniramine Oral Suspension [Pediatan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 6628 | Mannitol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 6628 | Mannitol | Designated preferred name (PT) | YES | |
RxCUI: 6628 | Mannitol | Full form of descriptor (FN) | YES | |
RxCUI: 6628 | Mannitol | Designated preferred name (PT) | YES | |
RxCUI: 6628 | Mannitol | Full form of descriptor (FN) | YES | |
RxCUI: 6629 | Mannitol dehydrogenase | Designated preferred name (PT) | NO | |
RxCUI: 6629 | Mannitol dehydrogenase | Full form of descriptor (FN) | NO |